Study finds surprising amount of bacterial resistance to standard antibiotic treatment of kidney infections.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000191:economics / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects; D017048:Health Care Costs; D006801:Humans; D011704:Pyelonephritis / Q000188:drug therapy* / Q000191:economics; D014296:Trimethoprim Resistance; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination